Wednesday, October 14, 2026 Never miss a recall or a rule change Get the free brief →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
Business & M&AHenry Schein names ITT CFO Emmanuel Caprais as new finance chiefyesterdayBusiness & M&AAbbVie Files Material Event: Botox/Juvéderm Pricing Shift6 weeks agoDevices & TechKorean toxin makers split as Daewoong and Hugel advance5 days agoDevices & TechHebei Zollvan Diode Laser Clears FDA 510(k)5 weeks agoBusiness & M&AHugel chases 1 trillion won in three years6 days agoDevices & TechVIOL Scarlet Pro Wins FDA 510(k) Clearance5 weeks agoBusiness & M&AAbbVie takes $216M charge on Q3 deals, cuts earningslast weekDevices & TechECHOLASER X4 Clears FDA 510(k) for General Surgery4 weeks agoDevices & TechDEKA and GeoMedics expand laser portfolio across Indialast weekRegulatoryAllergan gets Health Canada nod for Boey, a fast-acting short-duration toxin2 weeks agoDevices & TechBTL expands EXOMIND brain stimulation to OCD, adolescentslast weekDevices & TechSkinHealth Systems launches SkinStylus in six European marketslast week
Business & M&A

Court Bid Filed to Pause InMode Takeover Review — Shareholder Litigation Clouds Steel Partners Offer

Legal challenge to InMode's acquisition process introduces execution risk and potential delays to the Steel Partners deal.

Two people shaking hands over a desk signifies a business agreement or partnership.
Photo: Kindel Media / Pexels
1-YEAR MOVE
+3% −14%
INMD ▲1.0%
1-year price move by ticker
TickerCompany1-year change
INMDInMode Ltd.+1.0%

Get the free Inside MedSpa brief by email

The free Inside MedSpa brief · no card · unsubscribe anytime. Privacy.

A shareholder has filed a court motion seeking to pause InMode's review of the Steel Partners acquisition proposal, alleging procedural defects or conflicts of interest in the board's evaluation process. Such litigation is routine in M&A transactions but introduces execution risk and potential deal delays.

The motion likely centers on board independence, process fairness, or disclosure adequacy—standard shareholder-protection arguments. If granted, the pause could extend the review timeline, allowing competing bidders to emerge or forcing renegotiation of the Steel Partners offer. InMode's board will defend the process and seek expedited resolution.

Free alerts

Free: recall & rule-change alerts for your practice.

Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.

The free Inside MedSpa brief · no card · unsubscribe anytime. Privacy.

Shareholder litigation seeking to pause InMode's takeover review introduces execution risk and potential deal delays.

For practice owners holding InMode stock or considering device purchases, the litigation adds uncertainty but does not materially change the underlying business. However, prolonged M&A uncertainty can slow capital deployment and R&D investment. Monitor the August 5 earnings call for board commentary on the legal challenge and timeline expectations. A swift resolution (favorable or not) is preferable to prolonged limbo.

Source: original report ↗

Frequently asked questions

What does the shareholder lawsuit against InMode's Steel Partners deal mean for my practice?

The litigation introduces execution risk and potential deal delays, but does not immediately affect InMode's current device operations or support. However, prolonged M&A uncertainty can slow InMode's capital deployment and R&D investment, which may impact future product roadmaps and innovation cycles.

Can a shareholder lawsuit actually stop the InMode and Steel Partners acquisition?

A court-granted pause could delay the review timeline and allow competing bidders to emerge or force renegotiation of the Steel Partners offer. While such litigation is routine in M&A, it introduces real execution risk—though InMode's board will defend the process and seek expedited resolution.

What are shareholders claiming about InMode's board in this lawsuit?

The motion likely centers on board independence, process fairness, or disclosure adequacy—standard shareholder-protection arguments alleging procedural defects or conflicts of interest in the board's evaluation process. These are common claims in M&A litigation designed to protect minority shareholders.

When will we know if the InMode acquisition deal is actually happening?

Monitor InMode's August 5 earnings call for board commentary on the legal challenge and timeline expectations. A swift resolution—favorable or not—is preferable to prolonged limbo, so that call will likely provide the clearest near-term update on deal status.

Should I buy InMode devices now or wait until the Steel Partners deal is resolved?

The litigation does not materially change InMode's underlying business or device functionality. However, if you're planning major capital deployment, waiting for a swift resolution (or clarity on the August 5 call) may help you understand whether R&D investment and product innovation will be affected by prolonged M&A uncertainty.

Business information, not medical or legal advice. Verify product status at FDA.gov.

Free alerts

Free: recall & rule-change alerts for your practice.

Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.

The free Inside MedSpa brief · no card · unsubscribe anytime. Privacy.

Share

https://insidemedspa.com/article/inmode-court-bid-pause-takeover-review/

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Inside MedSpa · Free brief

    By the time it's news, it's too late.

    FDA decisions, recalls and the rules you operate under, drafted from the source documents and sent free by email.

    Get the free brief The free Inside MedSpa brief · no card · unsubscribe anytime.
    FDA, recalls and rule changes for practice owners Get the free brief →